All filters
Abstracts
The Contribution of HIV Viral Load in Improving the Accuracy of Recent Infection Testing in Rwanda
V. Mbonitegeka Reviews in Antiviral Therapy & Infectious Diseases 10, 2020  
Presented at:
INTEREST 2020
Abstracts
Point of Care SAMBA-II vs Central Laboratory monitoring of HIV-1 Infected Children, Adolescents and Young Adults in Rural Zimbabwe.
V. Kouamou Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Evaluation of Viral Load Coverage and Suppression Rates in the GlobalFund Impact HIV Project in Nigeria; June 2017 – November 2019
H. Adiamoh Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Post-market assessment of two rapid diagnostic test kits used in the diagnosis of HIV in the Wa Municipality, Ghana
D. Amoatika Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Best practices for statistical method comparison to evaluate new plasma separation devices as alternatives to plasma-based HIV viral load monitoring
T. Mampa  Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Pregnant women at higher risk of hepatotoxicity when initiating TDF/3TC/EFV in Malawi
E. Singogo Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Viral load access for key population implemented at community-based clinic in Mali
J. Bashi Bagendabanga Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
The Abbott Alinity m HIV-1 viral assay verified for testing PPT specimens in a centralised laboratory setting in South Africa
L. Hans Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Accessibility of Point-of-Care Diagnostics in Rural‬ and Remote Primary Health Care Facilities in Zambia: A Cross-Sectional Survey
J. Katoba Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
The performance of the cobas® plasma separation card for HIV viral load testing using the Abbott m2000 platform
L. Noble Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Performance Characteristics of a Modified HIV-1 Drug Resistance Genotyping Method for use in Resource Limited Settings
E. Magomere Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Verification of the BD FACSPresto™ machine for haemoglobin and CD4 cell counts testing in Kenya
C. Ogada  Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Ease of use, acceptability and diagnostic characteristics of Atomo HIV self-test kits among HIV Testing Services clients in Kenya
T. Nzomo Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
CD4/CD8 ratio is a strong predictor of failure to antiretroviral therapy among adolescents: evidence from the edctp-study in Cameroon
A. Nka Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Increasing Knowledge of Pre-Exposure Prophylaxis among Key Populations Led to Increased Uptake in Botswana
T. Dima Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
An Innovative Strategy for Increasing Demand for Oral Pre-exposure Prophylaxis among Female Sex Workers in Malawi
F. Gadama Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
It takes a village… of tactics to successfully drive demand creation for HIV prevention
E. Briedenhann Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Adherence among Adolescent Girls and Young Women Sex Workers on HIV Oral Pre-Exposure Prophylaxis in Mukono District, Uganda
G. Mirembe Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Male Sex Workers Discontinuation of PrEP Use? Client Thoughts as Captured in the Exit and Feedback Interviews
M. Mbuyi Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Perspectives and preferences of user/stakeholders for a microarray patch (MAP) for HIV PrEP and as a multipurpose prevention technology (MPT) in Uganda
A. Katahoire Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
End-user perspectives on their ability, motivation and opportunity to use the vaginal ring
K. Schwartz Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020
Abstracts
Mobile Health approaches to support follow-Up, retention and information dissemination among sero-discordant partners on Pre-Exposure Prophylaxis (PrEP) in Uganda
J. Ssebwana Reviews in Antiviral Therapy & Infectious Diseases 10, 2020
Presented at:
INTEREST 2020